Supplementary Material for: Supervised, Self-Administered Tablet-Based Cognitive Assessment in Neurodegenerative Disorders and Stroke

Introduction: As the population ages, the prevalence of cognitive impairment is expanding. Given the recent pandemic, there is a need for remote testing modalities to assess cognitive deficits in individuals with neurological disorders. Self-administered, remote, tablet-based cognitive assessments w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: K.L., Sloane, R., Fabian, A., Wright, S., Saxena, K., Kim, C.M., Stein, Z., Keser, S., Glenn, A.E., Hillis
Format: Dataset
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator K.L., Sloane
R., Fabian
A., Wright
S., Saxena
K., Kim
C.M., Stein
Z., Keser
S., Glenn
A.E., Hillis
description Introduction: As the population ages, the prevalence of cognitive impairment is expanding. Given the recent pandemic, there is a need for remote testing modalities to assess cognitive deficits in individuals with neurological disorders. Self-administered, remote, tablet-based cognitive assessments would be clinically valuable if they can detect and classify cognitive deficits as effectively as traditional in-person neuropsychological testing. Methods: We tested whether the Miro application, a tablet-based neurocognitive platform, measured the same cognitive domains as traditional pencil-and-paper neuropsychological tests. Seventy-nine patients were recruited and then randomized to either undergo pencil-and-paper or tablet testing first. Twenty-nine age-matched healthy controls completed the tablet-based assessments. We identified Pearson correlations between Miro tablet-based modules and corresponding neuropsychological tests in patients and compared scores of patients with neurological disorders with those of healthy controls using t tests. Results: Statistically significant Pearson correlations between the neuropsychological tests and their tablet equivalents were found for all domains with moderate (r > 0.3) or strong (r > 0.7) correlations in 16 of 17 tests (p < 0.05). All tablet-based subtests differentiated healthy controls from neurologically impaired patients by t tests except for the spatial span forward and finger tapping modules. Participants reported enjoyment of the tablet-based testing, denied that it provoked anxiety, and noted no preference between modalities. Conclusions: This tablet-based application was found to be widely acceptable to participants. This study supports the validity of these tablet-based assessments in the differentiation of healthy controls from patients with neurocognitive deficits in a variety of cognitive domains and across multiple neurological disease etiologies.
doi_str_mv 10.6084/m9.figshare.22360054
format Dataset
fullrecord <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_22360054</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_22360054</sourcerecordid><originalsourceid>FETCH-LOGICAL-d914-6f428aae95ffc8b6b7c2b1278bc2f3e385c5fe214b12849a612d4b6056253fa03</originalsourceid><addsrcrecordid>eNo1kM1OhDAUhdm4MKNv4KIPIFhK6RR3iL_JqAvYNxd6i438pe1M4gP43jLqrE5yv5uTnC-KrlKaCCr5zVgkxvb-AxwmjGWC0pyfR9_1flkGHHEK4L7IKwR0FgZiZndLVobuYD3qa1LjYOJSj3ayfv1BTRpoBwzxHaycVHM_2WAPSErv0ftjIbETecO9mzX2OKGDX35v_ew0Ok9g0qQObv7Ei-jMwODx8j83UfP40FTP8e796aUqd7EuUh4Lw5kEwCI3ppOtaLcda1O2lW3HTIaZzLvcIEv5epS8AJEyzVtBc8HyzADNNhH_q9UQoLMB1eLsuO5WKVVHSWos1EmSOknKfgDkZ2aE</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>Supplementary Material for: Supervised, Self-Administered Tablet-Based Cognitive Assessment in Neurodegenerative Disorders and Stroke</title><source>DataCite</source><creator>K.L., Sloane ; R., Fabian ; A., Wright ; S., Saxena ; K., Kim ; C.M., Stein ; Z., Keser ; S., Glenn ; A.E., Hillis</creator><creatorcontrib>K.L., Sloane ; R., Fabian ; A., Wright ; S., Saxena ; K., Kim ; C.M., Stein ; Z., Keser ; S., Glenn ; A.E., Hillis</creatorcontrib><description>Introduction: As the population ages, the prevalence of cognitive impairment is expanding. Given the recent pandemic, there is a need for remote testing modalities to assess cognitive deficits in individuals with neurological disorders. Self-administered, remote, tablet-based cognitive assessments would be clinically valuable if they can detect and classify cognitive deficits as effectively as traditional in-person neuropsychological testing. Methods: We tested whether the Miro application, a tablet-based neurocognitive platform, measured the same cognitive domains as traditional pencil-and-paper neuropsychological tests. Seventy-nine patients were recruited and then randomized to either undergo pencil-and-paper or tablet testing first. Twenty-nine age-matched healthy controls completed the tablet-based assessments. We identified Pearson correlations between Miro tablet-based modules and corresponding neuropsychological tests in patients and compared scores of patients with neurological disorders with those of healthy controls using t tests. Results: Statistically significant Pearson correlations between the neuropsychological tests and their tablet equivalents were found for all domains with moderate (r &gt; 0.3) or strong (r &gt; 0.7) correlations in 16 of 17 tests (p &lt; 0.05). All tablet-based subtests differentiated healthy controls from neurologically impaired patients by t tests except for the spatial span forward and finger tapping modules. Participants reported enjoyment of the tablet-based testing, denied that it provoked anxiety, and noted no preference between modalities. Conclusions: This tablet-based application was found to be widely acceptable to participants. This study supports the validity of these tablet-based assessments in the differentiation of healthy controls from patients with neurocognitive deficits in a variety of cognitive domains and across multiple neurological disease etiologies.</description><identifier>DOI: 10.6084/m9.figshare.22360054</identifier><language>eng</language><publisher>Karger Publishers</publisher><subject>Medicine</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,1887</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.22360054$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>K.L., Sloane</creatorcontrib><creatorcontrib>R., Fabian</creatorcontrib><creatorcontrib>A., Wright</creatorcontrib><creatorcontrib>S., Saxena</creatorcontrib><creatorcontrib>K., Kim</creatorcontrib><creatorcontrib>C.M., Stein</creatorcontrib><creatorcontrib>Z., Keser</creatorcontrib><creatorcontrib>S., Glenn</creatorcontrib><creatorcontrib>A.E., Hillis</creatorcontrib><title>Supplementary Material for: Supervised, Self-Administered Tablet-Based Cognitive Assessment in Neurodegenerative Disorders and Stroke</title><description>Introduction: As the population ages, the prevalence of cognitive impairment is expanding. Given the recent pandemic, there is a need for remote testing modalities to assess cognitive deficits in individuals with neurological disorders. Self-administered, remote, tablet-based cognitive assessments would be clinically valuable if they can detect and classify cognitive deficits as effectively as traditional in-person neuropsychological testing. Methods: We tested whether the Miro application, a tablet-based neurocognitive platform, measured the same cognitive domains as traditional pencil-and-paper neuropsychological tests. Seventy-nine patients were recruited and then randomized to either undergo pencil-and-paper or tablet testing first. Twenty-nine age-matched healthy controls completed the tablet-based assessments. We identified Pearson correlations between Miro tablet-based modules and corresponding neuropsychological tests in patients and compared scores of patients with neurological disorders with those of healthy controls using t tests. Results: Statistically significant Pearson correlations between the neuropsychological tests and their tablet equivalents were found for all domains with moderate (r &gt; 0.3) or strong (r &gt; 0.7) correlations in 16 of 17 tests (p &lt; 0.05). All tablet-based subtests differentiated healthy controls from neurologically impaired patients by t tests except for the spatial span forward and finger tapping modules. Participants reported enjoyment of the tablet-based testing, denied that it provoked anxiety, and noted no preference between modalities. Conclusions: This tablet-based application was found to be widely acceptable to participants. This study supports the validity of these tablet-based assessments in the differentiation of healthy controls from patients with neurocognitive deficits in a variety of cognitive domains and across multiple neurological disease etiologies.</description><subject>Medicine</subject><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2023</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNo1kM1OhDAUhdm4MKNv4KIPIFhK6RR3iL_JqAvYNxd6i438pe1M4gP43jLqrE5yv5uTnC-KrlKaCCr5zVgkxvb-AxwmjGWC0pyfR9_1flkGHHEK4L7IKwR0FgZiZndLVobuYD3qa1LjYOJSj3ayfv1BTRpoBwzxHaycVHM_2WAPSErv0ftjIbETecO9mzX2OKGDX35v_ew0Ok9g0qQObv7Ei-jMwODx8j83UfP40FTP8e796aUqd7EuUh4Lw5kEwCI3ppOtaLcda1O2lW3HTIaZzLvcIEv5epS8AJEyzVtBc8HyzADNNhH_q9UQoLMB1eLsuO5WKVVHSWos1EmSOknKfgDkZ2aE</recordid><startdate>20230330</startdate><enddate>20230330</enddate><creator>K.L., Sloane</creator><creator>R., Fabian</creator><creator>A., Wright</creator><creator>S., Saxena</creator><creator>K., Kim</creator><creator>C.M., Stein</creator><creator>Z., Keser</creator><creator>S., Glenn</creator><creator>A.E., Hillis</creator><general>Karger Publishers</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20230330</creationdate><title>Supplementary Material for: Supervised, Self-Administered Tablet-Based Cognitive Assessment in Neurodegenerative Disorders and Stroke</title><author>K.L., Sloane ; R., Fabian ; A., Wright ; S., Saxena ; K., Kim ; C.M., Stein ; Z., Keser ; S., Glenn ; A.E., Hillis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d914-6f428aae95ffc8b6b7c2b1278bc2f3e385c5fe214b12849a612d4b6056253fa03</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Medicine</topic><toplevel>online_resources</toplevel><creatorcontrib>K.L., Sloane</creatorcontrib><creatorcontrib>R., Fabian</creatorcontrib><creatorcontrib>A., Wright</creatorcontrib><creatorcontrib>S., Saxena</creatorcontrib><creatorcontrib>K., Kim</creatorcontrib><creatorcontrib>C.M., Stein</creatorcontrib><creatorcontrib>Z., Keser</creatorcontrib><creatorcontrib>S., Glenn</creatorcontrib><creatorcontrib>A.E., Hillis</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>K.L., Sloane</au><au>R., Fabian</au><au>A., Wright</au><au>S., Saxena</au><au>K., Kim</au><au>C.M., Stein</au><au>Z., Keser</au><au>S., Glenn</au><au>A.E., Hillis</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>Supplementary Material for: Supervised, Self-Administered Tablet-Based Cognitive Assessment in Neurodegenerative Disorders and Stroke</title><date>2023-03-30</date><risdate>2023</risdate><abstract>Introduction: As the population ages, the prevalence of cognitive impairment is expanding. Given the recent pandemic, there is a need for remote testing modalities to assess cognitive deficits in individuals with neurological disorders. Self-administered, remote, tablet-based cognitive assessments would be clinically valuable if they can detect and classify cognitive deficits as effectively as traditional in-person neuropsychological testing. Methods: We tested whether the Miro application, a tablet-based neurocognitive platform, measured the same cognitive domains as traditional pencil-and-paper neuropsychological tests. Seventy-nine patients were recruited and then randomized to either undergo pencil-and-paper or tablet testing first. Twenty-nine age-matched healthy controls completed the tablet-based assessments. We identified Pearson correlations between Miro tablet-based modules and corresponding neuropsychological tests in patients and compared scores of patients with neurological disorders with those of healthy controls using t tests. Results: Statistically significant Pearson correlations between the neuropsychological tests and their tablet equivalents were found for all domains with moderate (r &gt; 0.3) or strong (r &gt; 0.7) correlations in 16 of 17 tests (p &lt; 0.05). All tablet-based subtests differentiated healthy controls from neurologically impaired patients by t tests except for the spatial span forward and finger tapping modules. Participants reported enjoyment of the tablet-based testing, denied that it provoked anxiety, and noted no preference between modalities. Conclusions: This tablet-based application was found to be widely acceptable to participants. This study supports the validity of these tablet-based assessments in the differentiation of healthy controls from patients with neurocognitive deficits in a variety of cognitive domains and across multiple neurological disease etiologies.</abstract><pub>Karger Publishers</pub><doi>10.6084/m9.figshare.22360054</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.6084/m9.figshare.22360054
ispartof
issn
language eng
recordid cdi_datacite_primary_10_6084_m9_figshare_22360054
source DataCite
subjects Medicine
title Supplementary Material for: Supervised, Self-Administered Tablet-Based Cognitive Assessment in Neurodegenerative Disorders and Stroke
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T14%3A44%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=K.L.,%20Sloane&rft.date=2023-03-30&rft_id=info:doi/10.6084/m9.figshare.22360054&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_22360054%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true